Transforming CDMO Partnerships Through a Holistic Understanding of Quality
PATHEON SPONSORED CONTENT

Transforming CDMO Partnerships Through a Holistic Understanding of Quality

Bringing therapies to market requires working with a CDMO partner that embraces quality as a holistic endeavor affecting every aspect of the development process. To determine the CDMO partnership attributes that are essential to sponsors’ perception of quality performance, Thermo Fisher Scientific convened a focus group of high-performing pharma and biotech companies and conducted a series of independent interviews with participants. This white paper shares the results of that study, and identifies tools and best practices to drive continuous improvement, strengthen collaboration, and build trust. Download now to learn more.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.